{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:56:00Z","timestamp":1784346960664,"version":"3.55.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"CSIR, New Delhi","award":["09\/ 1051(0029)\/2 019-EMR-1"],"award-info":[{"award-number":["09\/ 1051(0029)\/2 019-EMR-1"]}]},{"name":"DST-FIST","award":["SR\/FST\/LS-I\/2017\/49"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2017\/49"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["RFC No. (p-64) NCD\/Adhoc\/139\/2020-21"],"award-info":[{"award-number":["RFC No. (p-64) NCD\/Adhoc\/139\/2020-21"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10072-022-06356-6","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T05:03:41Z","timestamp":1662440621000},"page":"19-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Madhumitha","family":"Katta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessy Aksa","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"Ludhiadch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8592","authenticated-orcid":false,"given":"Anjana","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"issue":"5","key":"6356_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBDN Collaborators","year":"2019","unstructured":"Collaborators GBDN (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"issue":"20","key":"6356_CR2","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.3390\/ijms21207609","volume":"21","author":"D Kuriakose","year":"2020","unstructured":"Kuriakose D, Xiao Z (2020) Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci 21(20):7609","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6356_CR3","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1161\/STROKEAHA.108.531632","volume":"40","author":"BR Broughton","year":"2009","unstructured":"Broughton BR, Reutens DC, Sobey CG (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40(5):e331\u2013e339","journal-title":"Stroke"},{"issue":"5","key":"6356_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.STR.0000160756.72109.95","volume":"36","author":"ML Flaherty","year":"2005","unstructured":"Flaherty ML et al (2005) Racial variations in location and risk of intracerebral hemorrhage. Stroke 36(5):934\u2013937","journal-title":"Stroke"},{"key":"6356_CR5","first-page":"368","volume":"29","author":"BK de Leon","year":"2006","unstructured":"de Leon BK, Zetterberg MJH (2006) Alzheimer\u2019s disease. Lancet 29:368","journal-title":"Lancet"},{"issue":"9\u201310","key":"6356_CR6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S135561771700100X","volume":"23","author":"MW Bondi","year":"2017","unstructured":"Bondi MW, Edmonds EC, Salmon D (2017) Alzheimer\u2019s disease: past, present, and future. J Int Neuropsychol Soc 23(9\u201310):818\u2013831","journal-title":"J Int Neuropsychol Soc"},{"issue":"10043","key":"6356_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler M, de Strooper B, Frisoni GB, Salloway S, van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 388(10043):505\u2013517","journal-title":"Lancet"},{"issue":"3","key":"6356_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-180766","volume":"67","author":"JL Cummings","year":"2019","unstructured":"Cummings JL, Tong G, Ballard C (2019) Treatment Combinations for Alzheimer\u2019s Disease: Current and Future Pharmacotherapy Options. J Alzheimers Dis 67(3):779\u2013794","journal-title":"J Alzheimers Dis"},{"key":"6356_CR9","doi-asserted-by":"crossref","unstructured":"Li HC, Luo KX, Wang JS, Wang QX (2020) Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: a case report. Medicine 99(11)","DOI":"10.1097\/MD.0000000000019443"},{"issue":"8","key":"6356_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: Etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6356_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR et al (2012) Parkinson\u2019s disease. Subcell Biochem 65:389\u2013455","journal-title":"Subcell Biochem"},{"issue":"S3","key":"6356_CR12","doi-asserted-by":"publisher","first-page":"S570","DOI":"10.1002\/mds.22019","volume":"23","author":"P Calabresi","year":"2008","unstructured":"Calabresi P et al (2008) Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord: Off J Mov Disord Soc 23(S3):S570\u2013S579","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"6356_CR13","first-page":"133","volume":"8","author":"BA Eyford","year":"2021","unstructured":"Eyford BA et al (2021) A nanomule peptide carrier delivers siRNA across the intact blood-brain barrier to attenuate ischemic stroke. Front Mol Biosci 8:133","journal-title":"Front Mol Biosci"},{"issue":"2","key":"6356_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5853\/jos.2019.00584","volume":"21","author":"JS Kim","year":"2019","unstructured":"Kim JS (2019) tPA helpers in the treatment of acute ischemic stroke: are they ready for clinical use? J Stroke 21(2):160","journal-title":"J Stroke"},{"issue":"2","key":"6356_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7861\/clinmedicine.17-2-161","volume":"17","author":"SE Tawil","year":"2017","unstructured":"Tawil SE, Muir KW (2017) Thrombolysis and thrombectomy for acute ischaemic stroke. Clin Med (Lond) 17(2):161\u2013165","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"6356_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1941874415587680","volume":"5","author":"CB O\u2019Carroll","year":"2015","unstructured":"O\u2019Carroll CB, Aguilar MI (2015) Management of postthrombolysis hemorrhagic and orolingual angioedema complications. Neurohospitalist 5(3):133\u2013141","journal-title":"Neurohospitalist"},{"key":"6356_CR17","doi-asserted-by":"crossref","unstructured":"Shah J, Liu S, Yu W (2022) Contemporary antiplatelet therapy for secondary stroke prevention: A narrative review of current literature and guidelines.\u00a0Stroke Vasc Neurol svn-2021","DOI":"10.1136\/svn-2021-001166"},{"issue":"20","key":"6356_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"J Mohr","year":"2001","unstructured":"Mohr J et al (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345(20):1444\u20131451","journal-title":"N Engl J Med"},{"issue":"2","key":"6356_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00002512-200421020-00001","volume":"21","author":"L Martinsson","year":"2004","unstructured":"Martinsson L, Eksborg S (2004) Drugs for Stroke Recovery. Drugs Aging 21(2):67\u201379","journal-title":"Drugs Aging"},{"key":"6356_CR20","doi-asserted-by":"crossref","unstructured":"Eyford BA, Singh CS, Abraham T, Munro L, Choi KB, Hill T, Hildebrandt R, Welch I, Vitalis TZ, Gabathuler R, Gordon JA (2021) A nanomule peptide carrier delivers siRNA across the intact blood-brain barrier to attenuate ischemic stroke.\u00a0Front Mol Biosci, p 133","DOI":"10.3389\/fmolb.2021.687587"},{"issue":"2","key":"6356_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/stem.1503","volume":"32","author":"W Fan","year":"2014","unstructured":"Fan W et al (2014) Caspase-3 modulates regenerative response after stroke. Stem Cells 32(2):473\u2013486","journal-title":"Stem Cells"},{"issue":"12","key":"6356_CR22","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1166\/jbn.2019.2866","volume":"15","author":"M Kim","year":"2019","unstructured":"Kim M et al (2019) Delivery of high mobility group box-1 siRNA using brain-targeting exosomes for ischemic stroke therapy. J Biomed Nanotechnol 15(12):2401\u20132412","journal-title":"J Biomed Nanotechnol"},{"key":"6356_CR23","unstructured":"Schneider LS (2022) A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.\u00a0Dialogues Clin Neurosci"},{"issue":"11","key":"6356_CR24","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","volume":"66","author":"DM Robinson","year":"2006","unstructured":"Robinson DM, Keating GM (2006) Memantine. Drugs 66(11):1515\u20131534","journal-title":"Drugs"},{"issue":"10","key":"6356_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn B (2021) Stein, and Cavazzoni, Approval of aducanumab for Alzheimer disease\u2014the FDA\u2019s perspective. JAMA Intern Med 181(10):1276\u20131278","journal-title":"JAMA Intern Med"},{"key":"6356_CR26","doi-asserted-by":"crossref","unstructured":"Chopade P, Chopade N, Zhao Z, Mitragotri S, Liao R, Chandran Suja V (2022) Alzheimer's and Parkinson's disease therapies in the clinic.\u00a0Bioeng Transl Med e10367","DOI":"10.1002\/btm2.10367"},{"issue":"4","key":"6356_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","volume":"22","author":"H Park","year":"2019","unstructured":"Park H et al (2019) In vivo neuronal gene editing via CRISPR\u2013Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease. Nat Neurosci 22(4):524\u2013528","journal-title":"Nat Neurosci"},{"issue":"13","key":"6356_CR28","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1073\/pnas.1820160116","volume":"116","author":"E Wong","year":"2019","unstructured":"Wong E et al (2019) GSAP modulates \u03b3-secretase specificity by inducing conformational change in PS1. Proc Natl Acad Sci 116(13):6385\u20136390","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"6356_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04238-0","volume":"9","author":"K Nagata","year":"2018","unstructured":"Nagata K et al (2018) Generation of App knock-in mice reveals deletion mutations protective against Alzheimer\u2019s disease-like pathology. Nat Commun 9(1):1\u20137","journal-title":"Nat Commun"},{"issue":"8","key":"6356_CR30","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/molecules22081287","volume":"22","author":"JK Lee","year":"2017","unstructured":"Lee JK, Kim N-J (2017) Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease. Molecules 22(8):1287","journal-title":"Molecules"},{"issue":"5","key":"6356_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/med.21309","volume":"34","author":"X Fan","year":"2014","unstructured":"Fan X et al (2014) Stem-cell challenges in the treatment of Alzheimer\u2019s disease: a long way from bench to bedside. Med Res Rev 34(5):957\u2013978","journal-title":"Med Res Rev"},{"key":"6356_CR32","doi-asserted-by":"crossref","unstructured":"Park D, Joo SS, Kim TK, Lee SH, Kang H, Lee HJ, Lim I, Matsuo A, Tooyama I, Kim YB, Kim SU (2012) Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. 365\u2013371","DOI":"10.3727\/096368911X586765"},{"issue":"2","key":"6356_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/stem.277","volume":"28","author":"JK Lee","year":"2010","unstructured":"Lee JK et al (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer\u2019s disease mice by modulation of immune responses. Stem cells 28(2):329\u2013343","journal-title":"Stem cells"},{"issue":"5","key":"6356_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/15672050113109990027","volume":"10","author":"J-S Bae","year":"2013","unstructured":"Bae J-S et al (2013) Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-\u03b2 deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer\u2019s disease. Curr Alzheimer Res 10(5):524\u2013531","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"6356_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.scr.2014.10.001","volume":"13","author":"K Takamatsu","year":"2014","unstructured":"Takamatsu K et al (2014) Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13(3):442\u2013453","journal-title":"Stem Cell Res"},{"key":"6356_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fnagi.2016.00282","volume":"8","author":"X Li","year":"2016","unstructured":"Li X et al (2016) Human neural stem cell transplantation rescues cognitive defects in APP\/PS1 model of Alzheimer\u2019s disease by enhancing neuronal connectivity and metabolic activity. Front Aging Neurosci 8:282","journal-title":"Front Aging Neurosci"},{"issue":"41","key":"6356_CR37","doi-asserted-by":"publisher","first-page":"eabc7031","DOI":"10.1126\/sciadv.abc7031","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou Y et al (2020) Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv 6(41):eabc7031","journal-title":"Sci Adv"},{"key":"6356_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2012.10.039","volume":"1490","author":"Y Liu","year":"2013","unstructured":"Liu Y et al (2013) Investigation of the performance of PEG\u2013PEI\/ROCK-II-siRNA complexes for Alzheimer\u2019s disease in vitro. Brain Res 1490:43\u201351","journal-title":"Brain Res"},{"issue":"3","key":"6356_CR39","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.nurpra.2015.10.020","volume":"12","author":"A Kriebel-Gasparro","year":"2016","unstructured":"Kriebel-Gasparro A (2016) Parkinson\u2019s disease: update on medication management. J Nurse Pract 12(3):e81\u2013e89","journal-title":"J Nurse Pract"},{"issue":"17","key":"6356_CR40","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","volume":"11","author":"SM Wilson","year":"2020","unstructured":"Wilson SM et al (2020) Classics in chemical neuroscience: pramipexole. ACS Chem Neurosci 11(17):2506\u20132512","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"6356_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40263-019-00646-y","volume":"33","author":"JE Frampton","year":"2019","unstructured":"Frampton JE (2019) Rotigotine transdermal patch: a review in Parkinson\u2019s disease. CNS Drugs 33(7):707\u2013718","journal-title":"CNS Drugs"},{"issue":"10","key":"6356_CR42","first-page":"622","volume":"42","author":"M Cruz","year":"2017","unstructured":"Cruz M (2017) Xadago (Safinamide): A Monoamine oxidase B inhibitor for the adjunct treatment of motor symptoms in Parkinson\u2019s disease. Pharm Ther 42(10):622","journal-title":"Pharm Ther"},{"issue":"8","key":"6356_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40263-018-0552-2","volume":"32","author":"J Paik","year":"2018","unstructured":"Paik J, Keam SJ (2018) Amantadine extended-release (GOCOVRI\u2122): a review in levodopa-induced dyskinesia in Parkinson\u2019s disease. CNS Drugs 32(8):797\u2013806","journal-title":"CNS Drugs"},{"issue":"4","key":"6356_CR44","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13311-020-00889-4","volume":"17","author":"SD Aradi","year":"2020","unstructured":"Aradi SD, Hauser RA (2020) Medical management and prevention of motor complications in Parkinson\u2019s disease. Neurotherapeutics 17(4):1339\u20131365","journal-title":"Neurotherapeutics"},{"issue":"2","key":"6356_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40120-021-00251-6","volume":"10","author":"F Agbo","year":"2021","unstructured":"Agbo F et al (2021) Pharmacokinetics and comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with parkinson\u2019s disease and \u201cOFF\u201d episodes: results of a randomized, three-way crossover, open-label study. Neurol Ther 10(2):693\u2013709","journal-title":"Neurol Ther"},{"issue":"6","key":"6356_CR46","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.stem.2016.03.014","volume":"18","author":"Y Chen","year":"2016","unstructured":"Chen Y et al (2016) Chemical control of grafted human PSC-derived neurons in a mouse model of Parkinson\u2019s disease. Cell Stem Cell 18(6):817\u2013826","journal-title":"Cell Stem Cell"},{"issue":"1","key":"6356_CR47","doi-asserted-by":"publisher","first-page":"114124","DOI":"10.15283\/ijsc18110","volume":"12","author":"J Lee","year":"2019","unstructured":"Lee J et al (2019) CRISPR\/Cas9 edited sRAGE-MSCs protect neuronal death in Parkinson\u2019s disease model. Int J Stem Cells 12(1):114124","journal-title":"Int J Stem Cells"},{"issue":"11","key":"6356_CR48","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor B et al (2018) Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD. Mol Ther 26(11):2638\u20132649","journal-title":"Mol Ther"},{"key":"6356_CR49","doi-asserted-by":"crossref","unstructured":"Liao YJ, Liao CH, Chen LR, Yang JR (2022) Dopaminergic neurons derived from porcine induced pluripotent stem cell like cells function in the Lanyu pig model of Parkinson's disease.\u00a0Anim Biotechnol 1\u201312","DOI":"10.1080\/10495398.2021.2020130"},{"issue":"R1","key":"6356_CR50","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","volume":"23","author":"F Zhang","year":"2014","unstructured":"Zhang F, Wen Y, Guo X (2014) CRISPR\/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet 23(R1):R40\u2013R46","journal-title":"Hum Mol Genet"},{"key":"6356_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","volume":"168","author":"N Savi\u0107","year":"2016","unstructured":"Savi\u0107 N, Schwank G (2016) Advances in therapeutic CRISPR\/Cas9 genome editing. Transl Res 168:15\u201321","journal-title":"Transl Res"},{"key":"6356_CR52","doi-asserted-by":"publisher","first-page":"118165","DOI":"10.1016\/j.lfs.2020.118165","volume":"259","author":"A Karimian","year":"2020","unstructured":"Karimian A et al (2020) CRISPR\/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases. Life Sci 259:118165","journal-title":"Life Sci"},{"key":"6356_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","volume":"11","author":"B Gy\u00f6rgy","year":"2018","unstructured":"Gy\u00f6rgy B et al (2018) CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer\u2019s disease. Mol Ther-Nucleic Acids 11:429\u2013440","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"2","key":"6356_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-170777","volume":"61","author":"R Thangavel","year":"2018","unstructured":"Thangavel R et al (2018) Co-expression of glia maturation factor and apolipoprotein E4 in Alzheimer\u2019s disease brain. J Alzheimers Dis 61(2):553\u2013560","journal-title":"J Alzheimers Dis"},{"key":"6356_CR55","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.scr.2018.11.010","volume":"34","author":"B Schmid","year":"2019","unstructured":"Schmid B et al (2019) Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line. Stem Cell Res 34:101349","journal-title":"Stem Cell Res"},{"issue":"5","key":"6356_CR56","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR et al (2019) Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. Ann Neurol 85(5):726\u2013739","journal-title":"Ann Neurol"},{"issue":"2","key":"6356_CR57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s12035-021-02638-w","volume":"59","author":"L Guan","year":"2022","unstructured":"Guan L et al (2022) CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders. Mol Neurobiol 59(2):968\u2013982","journal-title":"Mol Neurobiol"},{"issue":"Spec Iss","key":"6356_CR58","first-page":"281","volume":"10","author":"E Bayarsaikhan","year":"2015","unstructured":"Bayarsaikhan E et al (2015) Microglial AGE-albumin is critical for neuronal death in Parkinson\u2019s disease: a possible implication for theranostics. Int J Nanomed 10(Spec Iss):281","journal-title":"Int J Nanomed"},{"issue":"1","key":"6356_CR59","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13287-020-01762-z","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020) Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther 11(1):252\u2013252","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"6356_CR60","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","volume":"50","author":"ML Levy","year":"2019","unstructured":"Levy ML et al (2019) Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke 50(10):2835\u20132841","journal-title":"Stroke"},{"issue":"4","key":"6356_CR61","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/ijms21041306","volume":"21","author":"L Mazini","year":"2020","unstructured":"Mazini L et al (2020) Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing. Int J Mol Sci 21(4):1306","journal-title":"Int J Mol Sci"},{"key":"6356_CR62","first-page":"9","volume":"5","author":"S-T Tsai","year":"2021","unstructured":"Tsai S-T et al (2021) Stem cell therapy in stroke. Vessel Plus 5:9","journal-title":"Vessel Plus"},{"issue":"7","key":"6356_CR63","doi-asserted-by":"publisher","first-page":"e013583","DOI":"10.1161\/JAHA.119.013583","volume":"9","author":"MK Tobin","year":"2020","unstructured":"Tobin MK et al (2020) Activated mesenchymal stem cells induce recovery following stroke via regulation of inflammation and oligodendrogenesis. J Am Heart Assoc 9(7):e013583","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"6356_CR64","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jnr.21056","volume":"84","author":"Y Horita","year":"2006","unstructured":"Horita Y et al (2006) Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84(7):1495\u20131504","journal-title":"J Neurosci Res"},{"issue":"10046","key":"6356_CR65","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","volume":"388","author":"D Kalladka","year":"2016","unstructured":"Kalladka D et al (2016) Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet 388(10046):787\u2013796","journal-title":"Lancet"},{"key":"6356_CR66","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.biopha.2018.09.084","volume":"108","author":"C Nito","year":"2018","unstructured":"Nito C et al (2018) Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed Pharmacother 108:1005\u20131014","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"6356_CR67","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3727\/096368916X694391","volume":"26","author":"M Song","year":"2017","unstructured":"Song M et al (2017) Human dental pulp stem cells are more effective than human bone marrow-derived mesenchymal stem cells in cerebral ischemic injury. Cell Transplant 26(6):1001\u20131016","journal-title":"Cell Transplant"},{"issue":"18","key":"6356_CR68","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.3390\/ijms21186718","volume":"21","author":"S Suda","year":"2020","unstructured":"Suda S et al (2020) Recent advances in cell-based therapies for ischemic stroke. Int J Mol Sci 21(18):6718","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6356_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01927-w","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) Transplanted hair follicle stem cells migrate to the penumbra and express neural markers in a rat model of cerebral ischaemia\/reperfusion. Stem Cell Res Ther 11(1):1\u201312","journal-title":"Stem Cell Res Ther"},{"key":"6356_CR70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-981-15-4370-8_4","volume-title":"Stem Cell-based Therapy for Neurodegenerative Diseases","author":"F Han","year":"2020","unstructured":"Han F et al (2020) Stem cell therapy for Alzheimer\u2019s disease. Stem Cell-based Therapy for Neurodegenerative Diseases. Springer, pp 39\u201355"},{"key":"6356_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2014.00030","volume":"6","author":"KO Garcia","year":"2014","unstructured":"Garcia KO et al (2014) Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease. Front Aging Neurosci 6:30","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"6356_CR72","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"I-H Park","year":"2008","unstructured":"Park I-H et al (2008) Disease-specific induced pluripotent stem cells. Cell 134(5):877\u2013886","journal-title":"Cell"},{"issue":"1","key":"6356_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5966\/sctm.2016-0081","volume":"6","author":"M-Y Cha","year":"2017","unstructured":"Cha M-Y et al (2017) Protein-induced pluripotent stem cells ameliorate cognitive dysfunction and reduce A\u03b2 deposition in a mouse model of Alzheimer\u2019s disease. Stem Cells Transl Med 6(1):293\u2013305","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"6356_CR74","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hipo.22405","volume":"25","author":"RR Ager","year":"2015","unstructured":"Ager RR et al (2015) Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer\u2019s disease and neuronal loss. Hippocampus 25(7):813\u2013826","journal-title":"Hippocampus"},{"issue":"2","key":"6356_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neures.2008.06.005","volume":"62","author":"J Tang","year":"2008","unstructured":"Tang J et al (2008) Embryonic stem cell-derived neural precursor cells improve memory dysfunction in A\u03b2 (1\u201340) injured rats. Neurosci Res 62(2):86\u201396","journal-title":"Neurosci Res"},{"issue":"5","key":"6356_CR76","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.stemcr.2015.09.010","volume":"5","author":"W Yue","year":"2015","unstructured":"Yue W et al (2015) ESC-derived basal forebrain cholinergic neurons ameliorate the cognitive symptoms associated with Alzheimer\u2019s disease in mouse models. Stem Cell Reports 5(5):776\u2013790","journal-title":"Stem Cell Reports"},{"issue":"2","key":"6356_CR77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","volume":"13","author":"H Dana","year":"2017","unstructured":"Dana H et al (2017) Molecular mechanisms and biological functions of siRNA. Int J Biomed Sci: IJBS 13(2):48","journal-title":"Int J Biomed Sci: IJBS"},{"issue":"1","key":"6356_CR78","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/10717544.2020.1775724","volume":"27","author":"N Lopez-Barbosa","year":"2020","unstructured":"Lopez-Barbosa N et al (2020) Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer\u2019s. Drug Deliv 27(1):864\u2013875","journal-title":"Drug Deliv"},{"key":"6356_CR79","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.smaim.2020.08.001","volume":"1","author":"Z Wang","year":"2020","unstructured":"Wang Z et al (2020) SYNERGIC treatment of Alzheimer\u2019s disease with brain targeted nanoparticles incorporating NGR-Sirna and brain derived neurotrophic factor. Smart Mater Med 1:125\u2013130","journal-title":"Smart Mater Med"},{"issue":"8","key":"6356_CR80","first-page":"97","volume":"7","author":"A Dhall","year":"2018","unstructured":"Dhall A, Self W (2018) Cerium Oxide Nanoparticles: A Brief Review of Their Synthesis Methods and Biomedical Applications. Antioxidants (Basel, Switzerland) 7(8):97","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"6356_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","volume":"9","author":"C Helmschrodt","year":"2017","unstructured":"Helmschrodt C et al (2017) Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-Synuclein expression in a model of Parkinson\u2019s disease. Mol Ther-Nucleic Acids 9:57\u201368","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"10","key":"6356_CR82","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.1021\/acsami.0c22112","volume":"13","author":"R Li","year":"2021","unstructured":"Li R et al (2021) Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson\u2019s Disease Biomarkers. ACS Appl Mater Interfaces 13(10):11609\u201311620","journal-title":"ACS Appl Mater Interfaces"},{"issue":"12","key":"6356_CR83","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29(12):1476\u20131485","journal-title":"Mov Disord"},{"issue":"2","key":"6356_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ph13020031","volume":"13","author":"AG Pinho","year":"2020","unstructured":"Pinho AG et al (2020) Cell secretome: basic insights and therapeutic opportunities for CNS disorders. Pharmaceuticals 13(2):31","journal-title":"Pharmaceuticals"},{"issue":"12","key":"6356_CR85","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","volume":"95","author":"D Drago","year":"2013","unstructured":"Drago D et al (2013) The stem cell secretome and its role in brain repair. Biochimie 95(12):2271\u20132285","journal-title":"Biochimie"},{"issue":"2","key":"6356_CR86","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1586\/14789450.4.2.239","volume":"4","author":"Y Hathout","year":"2007","unstructured":"Hathout Y (2007) Approaches to the study of the cell secretome. Expert Rev Proteomics 4(2):239\u2013248","journal-title":"Expert Rev Proteomics"},{"issue":"11","key":"6356_CR87","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.bbapap.2013.01.022","volume":"1834","author":"P Mukherjee","year":"2013","unstructured":"Mukherjee P, Mani S (2013) Methodologies to decipher the cell secretome. Biochim Biophys Acta BBA Protein Proteomics 1834(11):2226\u20132232","journal-title":"Biochim Biophys Acta BBA Protein Proteomics"},{"issue":"11","key":"6356_CR88","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/sctm.18-0009","volume":"7","author":"B Mendes-Pinheiro","year":"2018","unstructured":"Mendes-Pinheiro B et al (2018) Secretome of undifferentiated neural progenitor cells induces histological and motor improvements in a rat model of Parkinson\u2019s disease. Stem Cells Transl Med 7(11):829\u2013838","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"6356_CR89","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR et al (2015) Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4(10):1131\u20131143","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"6356_CR90","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/jcp.24981","volume":"230","author":"W Huang","year":"2015","unstructured":"Huang W et al (2015) Paracrine factors secreted by MSCs promote astrocyte survival associated with GFAP downregulation after ischemic stroke via p38 MAPK and JNK. J Cell Physiol 230(10):2461\u20132475","journal-title":"J Cell Physiol"},{"issue":"1","key":"6356_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.31083\/j.jin.2020.01.1142","volume":"19","author":"Q Zhang","year":"2020","unstructured":"Zhang Q et al (2020) Neural stem cell secretome and its role in the treatment of neurodegenerative disorders. J Integr Neurosci 19(1):179\u2013185","journal-title":"J Integr Neurosci"},{"key":"6356_CR92","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fncel.2017.00381","volume":"11","author":"J Li","year":"2017","unstructured":"Li J et al (2017) Effect of VEGF on inflammatory regulation, neural survival, and functional improvement in rats following a complete spinal cord transection. Front Cell Neurosci 11:381","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"6356_CR93","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s12035-018-1109-6","volume":"56","author":"AE-E Aly","year":"2019","unstructured":"Aly AE-E et al (2019) Intranasal delivery of pGDNF DNA nanoparticles provides neuroprotection in the rat 6-hydroxydopamine model of Parkinson\u2019s disease. Mol Neurobiol 56(1):688\u2013701","journal-title":"Mol Neurobiol"},{"issue":"3","key":"6356_CR94","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/STROKEAHA.112.677328","volume":"44","author":"S Ishizaka","year":"2013","unstructured":"Ishizaka S et al (2013) Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44(3):720\u2013726","journal-title":"Stroke"},{"issue":"9","key":"6356_CR95","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","volume":"31","author":"W-R Sch\u00e4bitz","year":"2000","unstructured":"Sch\u00e4bitz W-R et al (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31(9):2212\u20132217","journal-title":"Stroke"},{"issue":"7","key":"6356_CR96","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/STROKEAHA.106.477331","volume":"38","author":"W-R Sch\u00e4bitz","year":"2007","unstructured":"Sch\u00e4bitz W-R et al (2007) Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38(7):2165\u20132172","journal-title":"Stroke"},{"issue":"3","key":"6356_CR97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1227\/01.NEU.0000290907.30814.42","volume":"61","author":"Y Miki","year":"2007","unstructured":"Miki Y et al (2007) Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. Neurosurgery 61(3):586\u2013595","journal-title":"Neurosurgery"},{"issue":"5","key":"6356_CR98","doi-asserted-by":"publisher","first-page":"e2774","DOI":"10.1038\/cddis.2017.184","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L et al (2017) Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia. Cell Death Dis 8(5):e2774\u2013e2774","journal-title":"Cell Death Dis"},{"issue":"3","key":"6356_CR99","doi-asserted-by":"publisher","first-page":"949","DOI":"10.5966\/sctm.2016-0111","volume":"6","author":"SH Oh","year":"2017","unstructured":"Oh SH et al (2017) The cleavage effect of mesenchymal stem cell and its derived matrix metalloproteinase-2 on extracellular \u03b1-synuclein aggregates in parkinsonian models. Stem Cells Transl Med 6(3):949\u2013961","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"6356_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.60.1.69","volume":"60","author":"J Nutt","year":"2003","unstructured":"Nutt J et al (2003) Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60(1):69\u201373","journal-title":"Neurology"},{"issue":"3","key":"6356_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.20737","volume":"59","author":"AE Lang","year":"2006","unstructured":"Lang AE et al (2006) Randomized controlled trial of intraputamenal glial cell line\u2013derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59(3):459\u2013466","journal-title":"Ann Neurol"},{"issue":"2","key":"6356_CR102","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen SJ et al (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138(2):155\u2013175","journal-title":"Pharmacol Ther"},{"key":"6356_CR103","doi-asserted-by":"publisher","unstructured":"Ahmed NEMB, Murakami M, Hirose Y, Nakashima M (2016) Therapeutic potential of dental pulp stem cell secretome for Alzheimer\u2019s disease treatment: an in vitro study.\u00a0Stem Cells Int\u00a08102478.\u00a0https:\/\/doi.org\/10.1155\/2016\/8102478","DOI":"10.1155\/2016\/8102478"},{"issue":"1","key":"6356_CR104","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G et al (2021) Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ 28(1):203\u2013218","journal-title":"Cell Death Differ"},{"key":"6356_CR105","doi-asserted-by":"crossref","unstructured":"Hijroudi F, Rahbarghazi R, Sadigh-Eteghad S, Bahlakeh G, Hassanpour M, Shimia M, Karimipour M (2022) Neural stem cells secretome increased neurogenesis and behavioral performance and the activation of Wnt\/\u03b2-Catenin signaling pathway in mouse model of Alzheimer\u2019s disease.\u00a0Neuromolecular Med 1\u201313","DOI":"10.1007\/s12017-022-08708-z"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06356-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T16:20:34Z","timestamp":1701015634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06356-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6356"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06356-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}